Form 4 for OKUR OnKure Therapeutics, Inc.
Accepted 2021-07-09 00:00:00 ET · period of report 2021-07-08 · accession 0001209191-21-046254 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-07-09 | 2021-07-08 | OKUR | Johnson Wendy S. | Chief Development Off | M - OptEx | $1.97 | +111.7K | 111.7K | New | +$220.1K |
| D | 2021-07-09 | 2021-07-08 | OKUR | Johnson Wendy S. | Chief Development Off | M - OptEx | $0.00 | -111.7K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-07-08 | M | A | 111,736 | $1.97 | 111,736 | D | — | — | |
| 2 | Derivative | Stock option (right to buy) | 2021-07-08 | M | D | 111,736 | $0.00 | 0 | D | $1.97 · 2017-09-01 to 2028-04-04 | 111,736 Common Stock |